These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27246159)

  • 41. An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array.
    Xia XR; Baynes RE; Monteiro-Riviere NA; Riviere JE
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):320-8. PubMed ID: 17493652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap.
    Williams PL; Riviere JE
    J Pharm Sci; 1989 Jul; 78(7):550-5. PubMed ID: 2674404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards a correlation between drug properties and in vitro transdermal flux variability.
    Frum Y; Khan GM; Sefcik J; Rouse J; Eccleston GM; Meidan VM
    Int J Pharm; 2007 May; 336(1):140-7. PubMed ID: 17182201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK; Arora V; Iversen PL; Brand RM
    Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of mechanistically defined chemical mixtures (MDCM) to assess mixture component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. II. Development of a general dermatopharmacokinetic model for use in risk assessment.
    Williams PL; Thompson D; Qiao GL; Monteiro-Riviere N; Riviere JE
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):487-96. PubMed ID: 8975773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How Sensitive Are Transdermal Transport Predictions by Microscopic Stratum Corneum Models to Geometric and Transport Parameter Input?
    Wen J; Koo SM; Lape N
    J Pharm Sci; 2018 Feb; 107(2):612-623. PubMed ID: 28989022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
    Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
    J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of physicochemical properties in the estimation of skin permeability: in vitro data assessment by Partial Least-Squares Regression.
    Chauhan P; Shakya M
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):481-94. PubMed ID: 20818583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
    Kumar D; Ali J; Baboota S
    Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A skin permeability model of insulin in the presence of chemical penetration enhancer.
    Yerramsetty KM; Neely BJ; Madihally SV; Gasem KA
    Int J Pharm; 2010 Mar; 388(1-2):13-23. PubMed ID: 20026200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modelling skin permeability with micellar liquid chromatography.
    Waters LJ; Shahzad Y; Stephenson J
    Eur J Pharm Sci; 2013 Nov; 50(3-4):335-40. PubMed ID: 23948555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery.
    Rim JE; Pinsky PM; van Osdol WW
    Ann Biomed Eng; 2005 Oct; 33(10):1422-38. PubMed ID: 16240090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC; Botner S
    Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linear free energy relationship analysis of permeability across polydimethylsiloxane (PDMS) membranes and comparison with human skin permeation in vitro.
    Liu X; Zhang K; Abraham MH
    Eur J Pharm Sci; 2018 Oct; 123():524-530. PubMed ID: 30107227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P; Jain A; Mitragotri S
    Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.